What does DOH Memo 2012-0154 include in the NBS panel of disorders?

DOH Memo 2012-0154 establishes guidelines for the National Newborn Screening (NBS) program in the Philippines, specifically outlining the disorders that are included in the screening panel. Maple Syrup Urine Disease (MSUD) is indeed one of the disorders listed in this memo as part of the NBS panel. It is a metabolic disorder caused by a deficiency of enzymes involved in the breakdown of certain amino acids, leading to potential severe health issues if not identified and managed early.

This inclusion ensures that infants diagnosed with MSUD can receive timely and appropriate medical intervention, which is crucial for improving long-term health outcomes. The early identification allows for dietary modifications that can prevent the accumulation of toxic substances, thereby significantly reducing the risk of serious complications associated with the disorder.

While Down Syndrome, Muscular Dystrophy, and Cystic Fibrosis are important health conditions, they are not included in the NBS panel detailed in DOH Memo 2012-0154, which specifically focuses on metabolic and genetic disorders that can be detected shortly after birth.